Pacific's Osteopatch enters US trial:
This article was originally published in Clinica
Pacific Biometrics has completed pilot clinical studies of the Osteopatch skin patch, designed for management of osteoporotic disease. The non-invasive system consists of a patented transdermal sweat collection device, assays for bone loss markers in sweat and a proprietary method for laboratory analysis. A US trial in 300 patients will begin soon and will take three to four months to complete, after which the company will make a 510(k) filing. 28 million people in the US are at risk for osteoporosis, a number that the National Osteoporosis Foundation believes will grow to 41 million by 2015.
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.